key: cord-1020099-4k5kjsd0
authors: Vlastarakos, Petros V.; Katsianos, Dimitrios
title: Steroid administration in the Covid-19 era; timing does matter!
date: 2020-11-12
journal: Eur Arch Otorhinolaryngol
DOI: 10.1007/s00405-020-06463-0
sha: baf4059b495fc056d75239065ce2f7c29bf51c49
doc_id: 1020099
cord_uid: 4k5kjsd0

nan

the chances of a positive outcome in critically ill patients, but also posing as a potential threat for patients, who have not yet surpassed the higher obstacles. Indeed, ENT surgeons should not overlook that the recent successful steroid administration in a SARS-CoV-2 patient with SSNHL reported by Koumpa et al. [8] involved a patient, who had already been discharged from ICU, whilst the successful steroid treatment of a post-SARS-CoV-2 anosmic patient reported by Touisserkani and Ayatollahi [9] was attempted when the PCR result was negative.

Hence, caution is warranted, when ENT surgeons are facing emergencies involving SSNHL or chemosensory deficits, and the pros and cons of steroid administration should be carefully weighed, taking not only the possibility of a SARS-CoV-2 infection into account but also the stage upon which the infection appears to lie. A multidisciplinary team working with infectious-disease specialist input represents the main mechanism of the optimal clinical decision-making in SARS-CoV-2 infection-perplexed ENT emergencies, in an effort to successfully guide patients throughout their disease trajectory.

The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study

Clinical practice guidelines for the management of olfactory dysfunction-secondary publication

Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study

COVID-19 infection and glucocorticoids: update from the Italian Society of Endocrinology Expert Opinion on steroid replacement in adrenal insufficiency

Antibody responses to SARS-CoV-2 in patients with COVID-19

Covid-19: low dose steroid cuts death in ventilated patients by one third, trial finds

Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China

Sudden irreversible hearing loss post COVID-19

Oral corticosteroid relieves post-COVID-19 anosmia in a 35-year-old patient